Figure 1. Structural Domains of Chick Agrin and of Fragments Used in This Study
Domains, potential sites for N-glycosylation, and glycosaminoglycan side chain attachment are shown. Location of alternatively spliced sites, including their amino acid sequences, are shown. Names of agrin fragments used in this study are given. As a help, the previously described construct c45A4B8 (stippled) is included.
blocks binding of agrin, have produced conflicting relower affinity. Binding of agrin to ␣-dystroglycan is not sults: while Gee et al. (1994) observed inhibition of agrinrequired for AChR aggregation, since the minimal fraginduced AChR clustering, Campanelli et al. (1994) rement sufficient for AChR aggregation, c21 B8 , does not ported an effect on the shape of, rather than the number bind to ␣-dystroglycan. Nevertheless, this fragment of, AChR clusters, and Sugiyama et al. (1994) did not binds to some other site on muscle cells. From this, we see any effects (see also Sealock and Froehner, 1994;  conclude that AChR aggregation is mediated by the Fallon and Hall, 1994) . Moreover, Sugiyama et al. (1994) binding of active agrin to a novel muscle cell receptor. observed that agrin isoforms, irrespective of their ability to induce AChR clusters, bound ␣-dystroglycan with Results similar affinities. It is therefore unlikely that binding of agrin to ␣-dystroglycan is sufficient to initiate AChR agFor our studies, we generated cDNA constructs of differgregation.
ent lengths as depicted in Figure 1 . Recombinant proWe recently found that a 21 kDa fragment containing teins were produced in eukaryotic COS7 or 293 cells only site B8 and the most C-terminal G domain (c21 B8 ;
and subsequently purified by immunoaffinity columns see Figure 1 ) is sufficient to induce AChR aggregation using MAb 5B1 (Reist et al., 1987; Gesemann et al., (Gesemann et al., 1995) . In contrast with a 45 kDa 1995). Individual G domains of agrin, namely G2 A4, G2A0, C-terminal fragment of active agrin A4B8 (c45 A4B8 ), which c21B8, and c21B0, were synthesized as glutathione consists of the last two G domains, c21 B8 no longer S-transferase (GST) fusion proteins in Escherichia coli. bound to heparin, and AChR aggregation induced by AChR-aggregating activity of c21 B8 expressed in E. coli this fragment was not inhibited by heparin (Gesemann was indistinguishable from c21 B8 expressed in COS7 et al., 1995) . This shows that agrin-induced AChR aggrecells (data not shown). gation per se is not inhibited by heparin. Because binding of rat agrin to ␣-dystroglycan is inhibited by heparin, we speculated that the heparin-binding site in agrin may
The Four Amino Acid Insert at Splice Site A be identical to the site interacting with ␣-dystroglycan.
Creates a Heparin-Binding Site In the current study, we compared binding of agrin Heparin inhibits both nerve-and agrin-induced AChR isoforms to heparin, ␣-dystroglycan, and muscle cells aggregation (Hirano and Kidokoro, 1989; Wallace, 1990 ; to address the following questions. First, are the do- Saito et al., 1993; Gesemann et al., 1995) , suggesting mains in agrin that are required for heparin binding identhat heparin/HSPGs may be involved in agrin-induced tical to those needed for ␣-dystroglycan binding? SecAChR aggregation. The finding that heparin also inhibond, is binding of agrin to ␣-dystroglycan sufficient for ited agrin binding to ␣-dystroglycan (Campanelli et al., AChR aggregation, and if not, is it necessary to induce 1994; Gee et al., 1994; Sugiyama et al., 1994) suggested AChR clusters? Third, do active agrin isoforms bind on that agrin may bind to this peripheral membrane protein muscle cells to a site distinct from ␣-dystroglycan? We via its heparin-binding site. As a consequence, binding find that the heparin-binding site of agrin maps to the of agrin to ␣-dystroglycan would not be requisite for second G-like domain and that the 4 amino acid insert AChR aggregation, since previous experiments have at site A is necessary for binding. We show that both shown that domains of agrin required for heparin binding heparin-binding and AChR-aggregating activity of agrin and those for AChR aggregation are distinct from each isoforms do not correlate with their affinity to ␣-dystroother (Gesemann et al., 1995) . The heparin-binding site glycan. The agrin isoform agrin A0B0, which does not bind characterized in these experiments is localized in the heparin and is inactive in AChR aggregation, binds second G domain and/or the last EGF-like domain of ␣-dystroglycan with high affinity; the agrin isoform agthe 45 kDa C-terminal fragment of agrin A4B8 (c45 A4B8 , see rin A4B8, which binds heparin and is active in AChR aggregation, binds to ␣-dystroglycan with up to ten times Figure 1 ). To compare heparin and ␣-dystroglycan binding of agrin, we aimed in a first set of experiments the 4 amino acid insert at site A would bind to this to map the heparin-binding site of agrin.
peripheral membrane protein.
Results obtained by Sugiyama et al. (1994) with rat agrin suggest, however, that Heparin-binding sites characterized in other proteins affinities of agrinA4B8 and agrinA0B0 to ␣-dystroglycan are often consist of clusters of basic amino acids that are similar. Under the assumption that the binding of rat flanked by hydrophobic amino acids (Cardin and Weinagrin to heparin also requires the 4 amino acid insert at traub, 1989). In fibronectin, such clusters of basic amino site A, these results suggest that the insert at site A is acids are essential for heparin binding (Barkalow and Schwarzbauer, 1991) . Within the region of chick agrin not required for the binding of agrin to ␣-dystroglycan. that is required for heparin binding, there is one such
To test this, we next measured binding of the 95 kDa cluster of basic amino acids, the alternatively spliced C-terminal fragments of agrinA4B8 and agrinA0B0 to chick insert at site A. To test the contribution of site A to skeletal muscle ␣-dystroglycan. heparin binding, we passed 35 S-labeled conditioned meFirst, transfer overlay assays with partially purified dium of COS7 cells that had been transiently transfected ␣-dystroglycan (Gee et al., 1993; Brancaccio et al., 1995 ) with different agrin constructs over heparin-Sepharose were performed. To demonstrate that binding of agrin columns. Flowthrough and eluate (0.5 M NaCl) of these isoforms was to ␣-dystroglycan, we probed fractions columns were immunoprecipitated with anti-c95 agrin with iodinated laminin-1 (EHS-laminin). As shown in Figantibodies and separated by SDS-polyacrylamide gel  ure 3A,   125 I-laminin-1 bound to a broad band of ‫081ف‬ electrophoresis (SDS-PAGE) as described (Gesemann kDa. The binding was Ca 2ϩ dependent and was abolet al., 1995) . As shown in Figure 2A (left), c95 A0B0 did not ished by 50 g/ml heparin. These binding characteristics bind to heparin-Sepharose, while c95 A4B8 did bind. Since were indistinguishable from those reported for the bindthese constructs differ by inserts at both sites A and B, ing of laminin-1 to ␣-dystroglycan from rabbit skeletal we examined next which site influences heparin binding.
muscle (Ibraghimov-Beskrovnaya et al., 1992 ; Ervasti While c95 A0B8 was not retained on the heparin column, and Campbell, 1993), providing strong evidence that the c95 A4B0 bound (Figure 2A, right) , demonstrating that the observed binding is to chick ␣-dystroglycan. Next, we 4 amino acid insert at site A and not the insert at site tested binding of 125 I-c95A4B8 and 125 I-c95A0B0. As shown B is required for heparin binding. This 4 amino acid in Figure 3A (middle), 2.5 nM 125 I-c95 A0B0 bound to the insert at site A was also required for heparin binding in same band as laminin-1, whereas the same concentrafull-length chick agrin (data not shown). The fragment tion of 125 I-c95 A4B8 gave only a very weak signal (right). G2 A4 (see Figure 1 ) was sufficient for heparin binding, Binding of 125 I-c95A4B8, however, was readily detected at and its binding also depended on the 4 amino acid insert 25 nM ( Figure 3A ). As was observed for laminin-1, bindat site A, as shown by the lack of binding of the fragment ing of both agrin isoforms was Ca 2ϩ dependent ( Figure  G2 A0 ( Figure 2B ). The peptide KSRK, which encodes the 3A; EDTA); 250 nM c95 A0B0 competed binding of 125 I-4 amino acid insert, however, was not sufficient, since laminin-1,
125
I-c95A4B8, and 125 I-c95A0B0. These results show 1 mM of this peptide did not compete with the binding that laminin-1 and both agrin isoforms bind to identical of agrin A4B8 to heparin columns (data not shown). Hence, or nearby sites on chick ␣-dystroglycan. The binding although the 4 amino acid insert at site A is required, of laminin-1, c95 A4B8 , and c95 A0B0 to ␣-dystroglycan in additional amino acids in the G2 domain also contribute membrane extracts of mouse C2C12 myotubes and to to form the heparin-binding site.
␣-dystroglycan of bovine peripheral nerve was very similar to that observed for ␣-dystroglycan from chick skeleAChR-Aggregating Activity of Agrin Isoforms tal muscle (data not shown; K. Matsumura, personal Negatively Correlates with Their communication), indicating that species differences beAffinity for ␣-Dystroglycan tween ␣-dystroglycan do not greatly influence the bindIf the heparin-binding site of agrin were identical with its ␣-dystroglycan-binding site, only agrin isoforms with ing of chick agrin isoforms. Our results are consistent Since in transfer overlay assays ␣-dystroglycan is denatured and agrin binding could not be readily quantified, we established a solid-phase radioligand binding assay. As seen by the nitrocellulose transfer overlay method, c95 A0B0 bound more strongly to ␣-dystroglycan than c95 A4B8 . At 78 pM, the difference was ‫-01ف‬fold (binding of c95 A0B0 /c95 A4B8 ϭ 10.6 Ϯ 2.7; mean Ϯ SEM; n ϭ 5) and at 1.25 nM was ‫-5ف‬fold (binding of c95A0B0/ c95A4B8 ϭ 4.6 Ϯ 0.6; mean Ϯ SEM; n ϭ 5; Figure 3B ). Hence, at ligand concentrations relevant for the AChRaggregating activity of c95A4B8, the agrin isoform that is inactive in inducing AChR aggregates binds to native ␣-dystroglycan more strongly than the active isoform. Unlabeled c95 A0B0 at a concentration of 1 M inhibited binding of both 125 I-c95 A0B0 and 125 I-c95 A4B8 to at least 90% ( Table 1) , showing that both agrin isoforms bind to the that 1 M c95 A4B8 is not sufficient to saturate the available Binding of 2.5 nM 125 I-laminin-1 is abolished by 10 mM EDTA ␣-dystroglycan binding sites. As observed by others (ϩ EDTA), 50 g/ml heparin (ϩ Hep.), or 250 nM unlabeled c95A0B0 (Bowe et al., 1994; Gee et al., 1994; Campanelli et al., (ϩ c95A0B0 fold lower affinity to ␣-dystroglycan than inactive c95 A0B0 . Note that (Table 1) . This is in agreement with the finding that the half-maximal AChR-aggregating activity of c95 A4B8 is reached at 35 4 amino acid insert at site A is required for heparin pM (Gesemann et al., 1995) .
binding. At higher heparin concentrations (>50 g/ml), ␣-dystroglycan binding of c95A0B0 was partially inhibited (data not shown), which may be due to unspecific, ionic with those obtained by Sugiyama et al. (1994) who obinterference of the polyanion heparin with the binding served that both isoforms of rat agrin bound to T. califorof c95A0B0 to ␣-dystroglycan. nica and mouse ␣-dystroglycan. Hence, the 4 amino acid insert required for heparin binding is not necessary for the binding of chick agrin to ␣-dystroglycan. Most AChR-Aggregating Activity and Dystroglycan importantly, our results show that c95A0B0, which is inacBinding of Active Agrin Can Be Uncoupled tive in AChR aggregation, binds to ␣-dystroglycan more
The data presented so far make it unlikely that ␣-dysstrongly than active c95A4B8. This shows that AChR-agtroglycan is the signal-transducing receptor for agrin. gregating activity of agrin isoforms does not correlate However, the low affinity binding of c95 A4B8 to ␣-dystroglycan could still be necessary for its AChR-aggregating with their affinity to ␣-dystroglycan.
activity. If AChR aggregation induced by agrin were independent of binding to ␣-dystroglycan, an agrin fragment that does not bind ␣-dystroglycan but that is active in inducing AChR aggregates might be found. Conversely, one might also expect to find a fragment of active agrin that still binds ␣-dystroglycan after deleting the domain responsible for AChR aggregation. To approach this, we measured binding to ␣-dystroglycan of the minimal fragment required for AChR aggregation (c21 B8 ) and a deletion mutant of c95 A4B8 that lacked the 21 kDa C-terminal end. The constructs lacking inserts at sites A and B were always included as controls.
First, we tested binding of the deletion constructs, called c95A0⌬c21 and c95A4⌬c21, to ␣-dystroglycan. These constructs, with an Mr of 74 kDa, are similar to the 70 kDa fragments purified from basal lamina extracts of the electric organ of T. californica that are inactive in inducing AChR aggregates on cultured muscle cells (Nitkin et al., 1987; Smith et al., 1992) . As shown in Figure  4A , both 125 I-labeled c95 A0 ⌬c21 and c95 A4 ⌬c21 bound to native and denatured ␣-dystroglycan with similar affinity, and more than 70% of their binding could be competed by 1 M unlabeled c95 A0B0 (see legend to Figure  4A ). This shows that fragments of chick agrin lacking the domain required for the induction of AChR aggregates are sufficient to bind ␣-dystroglycan. These results are reminiscent of those obtained by Ma et al. (1993) 1 M c95 A0B0 nor by 4 M unlabeled c21 B8 (see legend
The binding of 50 nM 125 I-c21B0 can be competed by 1 M c95A0B0 (24.2% Ϯ 1.6%; mean Ϯ SEM; n ϭ 3), indicating that c21B0 binds to Figure 4B ), indicating that c21 B8 does not bind to with low affinity to ␣-dystroglycan. In contrast with this, the counts ␣-dystroglycan and that the few counts are due to unobserved with 50 nM 125 I-c21B8 cannot be competed by 4 M unlaspecific binding. In summary, these data show that the beled c21 B8 (106.6% Ϯ 6.0%; mean Ϯ SEM; n ϭ 6) or by the ␣-capability of inducing AChR aggregation (c21 B8 ) and of dystroglycan-binding c95 A0B0 at 1 M (111.0% Ϯ 8.3%; mean Ϯ binding to ␣-dystroglycan (c95 A4,0 ⌬c21) can be uncou-SEM; n ϭ 6). Hence, the few counts at very high concentrations of pled. Therefore, this is strong evidence that binding of 125 I-c21B8 are most likely unspecific. Note that half-maximal AChRaggregating activity of c21 B8 is reached at 13 nM (Gesemann et al., agrinA4B8 to ␣-dystroglycan is not necessary to induce 1995).
AChR aggregation.
Agrin Fragments That Are Active in AChR also express ␣-dystroglycan; therefore, one would expect that the inactive deletion of c95 A4B8 , namely Aggregation Bind to a Novel Site on Muscle Cells c95 A4 ⌬c21, would also bind to muscle cells. As shown in Figure 5A , binding of c95 A0 ⌬c21 and c95 A4 ⌬c21 to Several lines of evidence suggest that AChR-aggregating activity of agrin is mediated by a signal-transducing chick myotubes was indeed very similar to their binding to purified ␣-dystroglycan (see Figure 4A ). Approxireceptor on muscle cells (McMahan, 1990) . Consequently, c21 B8 , which is active in AChR aggregation, mately 80% of the binding of 125 I-c95 A0 ⌬c21 and 125 Ic95 A4 ⌬c21 was inhibited by 1 M unlabeled c95 A0B0 (see should bind specifically to muscle cells. Chick myotubes than 40% with 1 M unlabeled c95A0B0, but they were not lowered with 4 M unlabeled c21 B8 (see legend to Figure 5B ). This suggests that some of the binding of c21B0 to muscle cells is due to its weak binding to ␣-dystroglycan. Although 1 M c95A0B0 saturates all the ␣-dystroglycan-binding sites available on chick myotubes (see below), the competition of 125 I-c21B0 was only partial, suggesting that the remaining counts are most likely due to nonspecific binding (see below). The significant binding of 125 I-c21 B8 to muscle cells was not inhibited by 1 M c95A0B0, but was inhibited by ‫%56ف‬ with 4 M unlabeled c21 B8 (see legend to Figure 5B ). In conjunction with the binding data on purified ␣-dystroglycan, these experiments are strong evidence that c21 B8 , the agrin fragment that is active in inducing AChR aggregation, binds to a novel site on muscle cells that is not ␣-dystroglycan.
Agrin-Binding Proteins and AChR Aggregation
We have documented earlier that induction of AChR aggregates by c21 B8 requires concentrations more than 300 times higher than those of c95 A4B8 (Gesemann et al., 1995) . Since c21 B8 binds neither to heparin (Gesemann et al., 1995) nor to ␣-dystroglycan (see Figure 4) , its lowered AChR-aggregating activity may be due to the lack of any of these binding sites. Alternatively, c21 B8 may bind to the putative signal-transducing receptor with lower affinity than c95 A4B8 for structural reasons.
To see to what extent binding to heparin or to ␣-dystroglycan (or to both) contributes to the AChRaggregating activity of agrin, we asked whether agrin fragments, which bind to one of the two binding partners but are inactive in aggregating AChRs, would influence cule distinct from ␣-dystroglycan that specifically binds c21B8.
was sufficient ( Figure 6B ). Competition with both active ligands, however, was incomplete (maximum of ‫,)%56ف‬ suggesting that the remaining counts were due to nonspecific binding. Indeed, counts in the same range were legend to Figure 5A ), indicating that they bind to measured when 125 I-c21 B8 was incubated on empty, gela-␣-dystroglycan.
tin-coated tissue culture dishes (data not shown). The Binding of 125 I-c21 B0 and 125 I-c21 B8 to muscle cells was ‫04ف‬ times higher efficiency of c95 A4B8 to bind to muscle clearly different from their binding to purified ␣-dystrocells indicates that the majority of the difference in the glycan. As shown in Figure 5B , c21 B0 bound only weakly efficacy to induce AChR aggregation is based on a deto muscle cells, while c21 B8 bound more strongly. The creased affinity of c21 B8 to the putative signal-transducing receptor. Binding of 125 I-c21 B8 was not competed by counts observed with 125 I-c21 B0 were inhibited to more 
E and F). AChRs, visualized by rhodamine-␣-bungarotoxin (A, C, and E). Muscle cellbound agrin, visualized as described in Experimental Procedures (B, D, and F). No staining of endogenous mouse agrin or c95 A4B8 used to induce AChR clusters is seen in control cultures (B)
. Incubation with c95 A0B0 results in a bright signal for muscle cell-bound c95 A0B0 (D). Some of the AChR clusters contain a higher density of c95 A0B0-binding sites, while in other clusters, no accumulation is seen (arrows). In contrast, muscle cell-bound c95 A4B8 (F) colocalizes with all AChR clusters (compare E and F). Scale bar represents 50 m.
agrin isoform may also be reflected by a difference in the distribution of the binding sites on muscle cells. We therefore looked at their distribution in cultured C2C12 Figure 6 . Diminished AChR-Aggregating Activity of c21B8 Is cells (Yaffe and Saxel, 1977) . Because of the greatly clusters was observed ( Figure 7B ). Incubation with 20 nM c95 A0B0 yielded a bright signal ( Figure 7D ). Since 1 M c95 A0B0 or 4 M c21 B0 ( Figure 6B ), which shows c95 A0B0 binds strongly to ␣-dystroglycan, this staining that only agrin isoforms that induce AChR aggregation most likely reflects the distribution of this peripheral bind to the receptor recognized by c21 B8 . membrane protein. As shown in Figures 7C and 7D , in The different binding characteristics of agrin isoforms some of the AChR clusters (arrows) agrin-like immunoreactivity was not accumulated. Colocalization of c95 A0B0 that are active in AChR aggregation and the inactive and AChR clusters was found in 55% Ϯ 2.3% (mean Ϯ SEM with n ϭ 10 tissue culture dishes; total of 801 clusters) of the cases. There was no significant difference in the degree of colocalization when AChR aggregates were located at the edge (59% Ϯ 2.6%) or inside of a myotube (52% Ϯ 3.5%). The accumulation of muscle cell-bound c95 A0B0 in AChR clusters is consistent with ␣-dystroglycan and other components of the DGC being concentrated in AChR aggregates in vitro (Gee et al., 1994; Campanelli et al., 1994; Sugiyama et al., 1994; Cohen et al., 1995) . Muscle cell-bound c95A4B8 showed an even higher degree of colocalization with AChR aggregates under our assay conditions ( Figure 7F ). In this case, 96% Ϯ 1.4% (mean Ϯ SEM with n ϭ 5 tissue culture dishes; total of 446 clusters tested) of the AChR aggregates stained brightly with anti-agrin antibodies. Hence, the existence of an additional binding site in c95 A4B8 is also reflected by a difference in the distribution by alternative mRNA splicing (Nitkin et al., 1987 ; Tsim by boxes (compare also Figure 1) . Ferns et al., 1993; Gesemann et al., 1995) . Since the focus of this study was to elucidate the mechabinding affinity between c95 A0B0 and c95 A4B8 is also found nisms underlying the synaptic activity of agrin, we have with ␣-dystroglycan from chicken heart, mouse C2C12 now characterized some of the binding partners of this myotubes, and bovine sciatic nerve (unpublished data). 95 kDa agrin fragment. We find that c95 A4B8 , which is It is therefore conceivable that binding of agrin A0B0 to highly active in inducing AChR aggregation, binds to at ␣-dystroglycan may help stabilizing the integrity of the least three molecules, namely heparin, ␣-dystroglycan, tissue in a manner similar to that proposed for laminin. and a novel site on muscle cells that most likely repreConsequently, binding of agrin A0B0 to ␣-dystroglycan sents the signal-transducing receptor for agrin ( Figure  may compensate for the loss of laminin and so lessen 8). In contrast with this, c95 A0B0, which is inactive in AChR the severity of some muscular dystrophies (for review aggregation, binds neither heparin nor the putative sigsee Campbell, 1995). nal-transducing receptor for agrin, but instead binds Interestingly, the agrin isoform agrin A0B0 is expressed strongly to ␣-dystroglycan (Figure 8) . very early in the developing spinal cord and only later, when neurons differentiate, sequences at sites A and B are inserted to create an agrin isoform that binds much Agrin Expressed by Non-Neuronal Cells Binds ␣-Dystroglycan less to ␣-dystroglycan, but concomitantly becomes functional in inducing aggregation of AChRs (McMahan The finding that agrin A0B0 , which is inactive in AChR aggregation, binds ␣-dystroglycan more strongly than et al., 1992; Ma et al., 1995; L. S. Honig, M. J. Werle, S. E. Horton, and M. A. R., unpublished data). Hence, agrin A4B8 provides evidence for a physiological role of this agrin isoform. Transcripts encoding agrin A0B0 are the strong binding of agrin to ␣-dystroglycan may be important early in neural development, while the residual highly expressed in non-neuronal tissue (e.g., muscle, sciatic nerve, heart, and kidney; Ruegg et al., 1992;  ␣-dystroglycan binding of the active agrin isoform may have little significance in the formation of the NMJ (see McMahan et al., 1992; Hoch et al., 1993; Ma et al., 1994) . All these tissues are also positive for agrin-like immunobelow). reactivity (Reist et al., 1987; Godfrey et al., 1988; Fallon and Gelfman, 1989; Rupp et al., 1991; Godfrey, 1991;  Role of Heparin and ␣-Dystroglycan Binding in AChR Aggregation Hoch et al., 1993) , and they also express ␣-dystroglycan (Ibraghimov-Beskrovnaya et al., 1992; Yamada et al., We show that the heparin-binding site of agrin requires the alternatively spliced insert (Lys-Ser-Arg-Lys) at site 1994; Durbeej et al., 1995) . The 95 kDa C-terminal fragment of chick agrin A0B0 binds ␣-dystroglycan from the A (Figure 2 ). The sequence of this insert is identical in the marine ray, rat, and mouse (Rupp et al., 1991 ; bovine sciatic nerve, and agrin-like immunoreactivity colocalizes with ␣-dystroglycan in the outermost layer Smith et al., 1992) , suggesting that the function to bind heparin is conserved across species. Alternative splicof the myelin sheaths (K. Matsumura, personal communication). In addition, the up to 10-fold difference in ing of agrin transcripts at sites A and B is coordinated such that isoforms with inserts at site B always contain the size and shape of the AChR clusters was seen (unpublished data). In addition, the size of AChR clusters the 4 amino acid insert at site A (Ruegg et al., 1992; Hoch et al., 1993) . Hence, agrin isoforms synthesized induced by the non-dystroglycan-binding c21 B8 does not differ from those induced by c95 A4B8 (unpublished data). by neurons contain the 4 amino acid insert Ma et al., 1995 ; L. S. Honig, M. J. Werle, These results suggest that the size of the AChR aggregates is not influenced by the interaction of neural agrin S. E. Horton, and M. A. R., unpublished data) and consequently bind heparin. Binding of heparin abolishes the with ␣-dystroglycan.
The slight inhibition of agrin-induced AChR aggregaAChR-aggregating activity of agrin (Wallace, 1990) , unless the nonheparin binding fragment c21 B8 is used to tion by c95 A0B0 may also explain why Gee et al. (1994) observed inhibition of agrin-induced AChR aggregation induce AChR aggregation (Gesemann et al., 1995) . Binding of heparin to the G2 domain of agrin may prevent the with MAb IIH6. This antibody, like c95A0B0, blocks the binding of agrin to ␣-dystroglycan. In these experiments, interaction of agrin either with heparin-like molecules or with the putative signaling receptor. We favor the secthe amount of agrin used to induce AChR aggregation was so little that a slight shift in the dose-response ond possibility because even a 50,000-fold excess of the heparin-binding domain G2A4 does not affect AChRrelation may have resulted in an apparently complete block of AChR aggregation. On the other hand, the failaggregating activity of c95A4B8 and the nonheparin-binding fragment c95 A0B8 has similar AChR-aggregating acure of Sugiyama et al. (1994) to observe inhibition could be due to higher concentrations of active agrin used for tivity as c95 A4B8 (unpublished data; see also Ferns et al., 1993) .
the induction of AChR clusters. The binding of agrin to ␣-dystroglycan seems not to The concentration of c21 B8 required to induce halfmaximal AChR clustering (EC 50 ) is ‫31ف‬ nM, while the play a role in transferring a signal for AChR aggregation to the inside of the muscle cells. We propose that it may EC 50 of c95 A4B8 is ‫53ف‬ pM (Gesemann et al., 1995) . How can our data explain this difference in activity? In previrather have a structural role in AChR aggregation. The finding that rapsyn (previously called 43 kDa protein) ous work, we speculated that the difference may be based on the loss of binding of c21B8 to a helper protein.
links dystroglycan and AChRs when transiently expressed in quail fibroblasts (Apel et al., 1995) has proAs candidates for such a helper, we proposed ␣-dystroglycan or HSPGs (or both). This suggestion was also vided evidence for such a role. Association of AChRs with the DGC via rapsyn may attach AChRs to the cybased on the observation that myogenic cell lines with a deficiency in glycosaminoglycan synthesis are less toskeleton and hence be necessary for the formation of clusters. Consistent with this, muscle fibers that are responsive to active agrin isoforms (Ferns et al., 1992 (Ferns et al., , 1993 Gordon et al., 1993) . Consistent with the idea that deficient in rapsyn fail to form AChR clusters in vivo and in response to agrin in vitro, and there is no accumulation ␣-dystroglycan is the cause for this difference in efficacy, these cell lines express ␣-dystroglycan that binds of the DGC at the NMJ in vivo (Gautam et al., 1995) . agrin less efficiently (Campanelli et al., 1994; Sugiyama et al., 1994) . We have now specifically looked at the Mechanism of Agrin-Induced possibility of ␣-dystroglycan being a helper protein by AChR Aggregation measuring AChR aggregation induced by c95 A4B8 in the Our data indicate that the difference in AChR aggregapresence of 200 nM of inactive c95 A0B0 , a concentration tion between agrin isoforms is based on the affinity with that is sufficient to block all the ␣-dystroglycan-binding which they bind to a novel site on muscle cells. This sites on the myotubes. We observed a 2-to 3-fold shift site most likely represents the long sought signal-transof the dose-response curve to higher concentrations ducing receptor for agrin for the following reasons: bind-( Figure 6A ), indicating that the lack of the binding site ing to this site is selective for agrin fragments that are for ␣-dystroglycan in c21B8 accounts only for an approxiactive in inducing AChR aggregates ( Figure 6B ) and mately 3-fold loss in AChR-aggregating activity. It is binding to this site on C2C12 muscle cells also induces therefore unlikely that the weaker binding of agrin to phosphorylation of the ␤ subunit of AChRs (T. Meier ␣-dystroglycan expressed in these GAG-deficient cells and B. G. Wallace, personal communication) . The recent is the molecular basis for their decreased responidentification of neuroligin 1, a ligand that is only recogsiveness to agrin.
nized by one specific isoform of the ␤-neurexins (IchtOur results, however, are compatible with a role of chenko et al., 1995) , has demonstrated that alternative ␣-dystroglycan in binding neural agrin locally to the sursplicing can be a means to regulate specificity of ligandface of the muscle cell. The aggregation of the DGC at receptor interactions. Agrin isoforms are an additional agrin-induced AChR clusters (Campanelli et al., 1994;  example for such a mechanism. Gee et al., 1994; Sugiyama et al., 1994; Cohen et al., The competition experiments indicate that most of 1995) increases the number of agrin-binding sites. As the loss of the AChR-aggregating activity of c21B8 is due proposed by Cohen et al. (1995) , this would allow the to its diminished affinity to the putative agrin receptor binding of additional neural agrin at AChR clusters and, ( Figure 6B ). This implies that high affinity binding of agrin consequently, small clusters could become bigger. This to this receptor involves sequences N-terminal to the model would be consistent with the observation that last G domain. This is supported by the findings that the anti-␣-dystroglycan MAb IIH6, which blocks binding splicing at site A affects AChR aggregation (while soluof agrin, affects the shape of agrin-and nerve-induced ble agrin A4B0 has some AChR aggregating at high conAChR clusters (Campanelli et al., 1994; Cohen et al., centrations, agrin A0B0 is inactive [Ferns et al., 1993; Gese-1995) . However, when we blocked binding of c95 A4B8 to ␣-dystroglycan with an excess of c95 A0B0 , no effect on mann et al. , 1995] ) and that MAbs directed against the Skeletal muscle ␣-dystroglycan was purified either by DEAE chro-G2 domain in rat agrin block its AChR-aggregating activmatography followed by a WGA affinity column or on a laminin ity (Hoch et al., 1994) .
fragment E3 affinity column as described by Brancaccio et al. (1995 (Jennings et al., 1993; Valenzuela et al., 1995 (Ferns et al., 1992 (Ferns et al., , 1993 Gordon et al., 1993) .
coding the second G domain of agrin, pG2A0 and pG2A4, were generated by PCR using pc95 A0B0 and pc95A4B8 as template and the primers Our data suggest that sites in agrin that are involved see Apel and Merlie, 1995) . We have now generated the tools that enable us to distinguish binding of active agrin
Labeling of Agrin

35
S labeling of recombinant agrin fragment expressed in COS and to the different binding partners on muscle cells, which 293 cells was done as previously described (Gesemann et al., 1995) .
will facilitate the identification of this signal-transducing
Iodinations of agrin fragments were done by the chloramin T method receptor.
described by Hunter and Greenwood (1962) with minor modification. The labeling reaction was carried out with 20-100 g of protein dissolved in TBS, and the protein solution was supplemented with Experimental Procedures 100 l of 0.5 M potassium-phosphate buffer (pH 7.0). After adding 0.5 to 1 Ci of Na-[ 125 I] (New England Nuclear-DuPont), the labeling Cell Culture and Transfection reaction was started with 10 l of a chloramin T solution (2 mg/ml Primary chick myotubes or myotubes from the mouse cell line C2C12 chloramin T dissolved in 0.05 M K-phosphate buffer [pH 7.0]). After were prepared as previously described (Gesemann et al., 1995) . 45 s, the labeling reaction was stopped with 10 l of 2 mg/ml Na 2S2O5 Transfection of COS or 293 cells were carried out as described by in 0.05 M K-phosphate buffer (pH 7.0). Free 125 I was separated from Gesemann et al. (1995) .
labeled proteins by gel filtration with G25-Sepharose (Pharmacia). Columns were equilibrated and eluted with MEM (GIBCO), 20 mM HEPES (pH 7.2) (H-MEM), 0.1% bovine serum albumin (BSA), 100 Purification of Agrin and ␣-Dystroglycan U/ml penicillin, and 100 g/ml streptomycin. More than 80% of the Agrin isoforms expressed in COS or 293 cells were purified with protein was recovered after gel filtration. Radioactivity incorporated MAb 5B1 affinity columns as previously described (Gesemann et per microgram of protein was determined by separating known al., 1995). Individual domains of agrin were expressed as GST fusion amounts of protein by SDS-PAGE and quantitation with a phosporproteins in bacteria. Purification was as follows. Overnight cultures imager. In the binding curves of each individual experiment, counts of E. coli (JM-109) transformed with the recombinant expression for different agrin fragments were corrected for differences in incorvector PGEX-2t (Pharmacia) were diluted 1:100 in fresh LB medium poration of 125 I. Note that therefore only values within one individual containing 50 g/ml ampicillin and grown at 37ЊC until OD 600 reached experiment can be compared with each other, but not between 0.8. Fusion proteins were then induced by adding IPTG to a final different experiments. The biological activity of all active agrin fragconcentration of 0.5 mM, and cells were grown for an additional ments was retained after iodination as measured by their ability to 5-6 hr. Cells were pelleted and resuspended in 1/100 culture volume induce AChR clusters on cultured chick myotubes. of PBS, lysed on ice by mild sonication, and centrifuged at 39,000 ϫ g for 20 min at 4ЊC. The supernatant was loaded onto a 2 ml glutathione-Sepharose 4B column (Pharmacia) and washed with Solid-Phase Radioligand Binding Assay ␣-Dystroglycan was immobilized on microtiter plates by incubation 10-20 bed volumes of PBS. The fusion protein was eluted with 10 ml of freshly prepared 10 mM reduced glutathione in 50 mM Tris-HCl overnight at 4ЊC in 50 mM sodium carbonate (pH 9.6). Remaining binding sites were saturated by incubation with TBS, 2% fetal calf (pH 8.0). Eluates were dialyzed versus 50 mM Tris-HCl (pH 8.5), 150 mM NaCl. CaCl 2 was then added to a final concentration of 2.5 mM, serum, 1 mg/ml BSA. After three washes with TBS containing 1.25 mM CaCl 2 and 1 mM MgCl 2 (TBS ϩCa/ϩMg ), 125 I-agrin fragments were and proteins were subjected to thrombin digestion for 1-2 hr at room temperature. The digested protein was reloaded on the glutaadded and incubated at room temperature for 3 hr in TBS ϩCa/ϩMg containing 3% BSA. The plates were washed four times with thione-Sepharose 4B column, and the flowthrough was collected. Recombinant agrin fragments were analyzed by SDS-PAGE, and TBS ϩCa/ϩMg , and bound radioactivity in each well was counted with a gamma counter. the concentration was determined by the Bio-Rad DC protein assay.
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